As of 2024-12-12, the Intrinsic Value of USANA Health Sciences Inc (USNA) is
62.88 USD. This USNA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 37.74 USD, the upside of USANA Health Sciences Inc is
66.60%.
The range of the Intrinsic Value is 55.88 - 73.58 USD
62.88 USD
Intrinsic Value
USNA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
55.88 - 73.58 |
62.88 |
66.6% |
| DCF (Growth 10y) |
62.20 - 81.80 |
69.99 |
85.5% |
| DCF (EBITDA 5y) |
59.49 - 86.24 |
66.21 |
75.4% |
| DCF (EBITDA 10y) |
63.90 - 90.52 |
71.26 |
88.8% |
| Fair Value |
14.26 - 14.26 |
14.26 |
-62.23% |
| P/E |
62.84 - 92.96 |
77.37 |
105.0% |
| EV/EBITDA |
49.88 - 82.73 |
64.06 |
69.8% |
| EPV |
64.41 - 78.61 |
71.51 |
89.5% |
| DDM - Stable |
21.35 - 41.97 |
31.66 |
-16.1% |
| DDM - Multi |
35.23 - 55.06 |
43.06 |
14.1% |
USNA Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
719.32 |
| Beta |
0.76 |
| Outstanding shares (mil) |
19.06 |
| Enterprise Value (mil) |
354.44 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.23% |
| Cost of Debt |
4.48% |
| WACC |
8.22% |